Skip to main content

Advertisement

Log in

Circulating CD34+ cells are elevated in neonates with respiratory distress syndrome

  • Original Research Paper
  • Published:
Inflammation Research Aims and scope Submit manuscript

Abstract

Objectives

The objective of the paper was to determine whether circulating stem-progenitor cells were elevated along with its mobilizing cytokines in neonatal respiratory distress syndrome (RDS).

Subjects and methods

Circulating CD34+ cells were identified by flow cytometry in 41 RDS in comparison with 20 preterm and 14 term controls without diffuse lung diseases. Plasma concentrations of vascular endothelial growth factor, stromal cell-derived factor-1 (SDF-1) and granulocyte–macrophage colony-stimulating factor were determined by immunochemical assays.

Results

The number of CD34+ cells was significantly higher in RDS [25(6–174) cells/μl] than in the preterm controls [15(1–100) cells/μl, P < 0.05]. RDS survivors had higher level of CD34+ cells than non-survivors (P < 0.05), and low CD34+ cell level in RDS was correlated with prolonged duration of ventilation (r = −0.396, P < 0.05). Likewise, the CD34+ cell level was inversely associated with Score for Neonatal Acute Physiology Perinatal Extension II (r = −0.473, P < 0.01) in RDS. Plasma SDF-1 concentration was significantly higher in RDS than in the preterm controls (P < 0.01), and was correlated with the level of CD34+ cells (r = 0.305, P < 0.01).

Conclusions

The level of circulating CD34+ cells was elevated in RDS along with an increase of plasma SDF-1, suggesting CD34+ cells might be involved in reparation of neonatal lung injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Mariani GL, Carlo WA. Ventilatory management in neonates. Science or art? Clin Perinatol. 1998;25:33–48.

    CAS  PubMed  Google Scholar 

  2. Lukkarinen HP, Laine J, Kääpä PO. Lung epithelial cells undergo apoptosis in neonatal respiratory distress syndrome. Pediatr Res. 2003;53:254–9.

    CAS  PubMed  Google Scholar 

  3. Yamada M, Kubo H, Kobayashi S, Ishizawa K, Numasaki M, Ueda S, et al. Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. J Immunol. 2004;172:1266–72.

    CAS  PubMed  Google Scholar 

  4. Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol. 2007;179:1855–63.

    CAS  PubMed  Google Scholar 

  5. Ishizawa K, Kubo H, Yamada M, Kobayashi S, Numasaki M, Ueda S, et al. Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema. FEBS Lett. 2004;556:249–52.

    Article  CAS  PubMed  Google Scholar 

  6. Kleeberger W, Versmold A, Rothamel T, Glockner S, Bredt M, Haverich A, et al. Increased chimerism of bronchial and alveolar epithelium in human lung allografts undergoing chronic injury. Am J Pathol. 2003;162:1487–94.

    PubMed  Google Scholar 

  7. Kotton DN, Ma BY, Cardoso WV, Sanderson EA, Summer RS, Williams MC, et al. Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development. 2001;128:5181–8.

    CAS  PubMed  Google Scholar 

  8. Palange P, Testa U, Huertas A, Calabrò L, Antonucci R, Petrucci E, et al. Circulating haemopoietic and endothelial progenitor cells are decreased in COPD. Eur Respir J. 2006;27:529–41.

    Article  CAS  PubMed  Google Scholar 

  9. Fadini GP, Schiavon M, Cantini M, Baesso I, Facco M, Miorin M, et al. Circulating progenitor cells are reduced in patients with severe lung disease. Stem Cells. 2006;24:1806–13.

    Article  PubMed  Google Scholar 

  10. Gehling UM, Ergün S, Schumacher U, Wagener C, Pantel K, Otte M, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood. 2000;95:3106–12.

    CAS  PubMed  Google Scholar 

  11. Yamada M, Kubo H, Ishizawa K, Kobayashi S, Shinkawa M, Sasaki H. Increased circulating endothelial progenitor cells in patients with bacterial pneumonia: evidence that bone marrow derived cells contribute to lung repair. Thorax. 2005;60:410–3.

    Article  CAS  PubMed  Google Scholar 

  12. Burnham EL, Taylor WR, Quyyumi AA, Rojas M, Brigham KL, Moss M. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am J Respir Crit Care Med. 2005;172:854–60.

    Article  PubMed  Google Scholar 

  13. Bizzarro MJ, Bhandari V, Krause DS, Smith BR, Gross I. Circulating stem cells in extremely preterm neonates. Acta Paediatr. 2007;96:521–5.

    Article  PubMed  Google Scholar 

  14. Balasubramaniam V, Mervis CF, Maxey AM, Markham NE, Abman SH. Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2007;292:L1073–84.

    Article  CAS  PubMed  Google Scholar 

  15. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 1999;18:3964–72.

    Article  CAS  PubMed  Google Scholar 

  16. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet. 2003;362:697–703.

    Article  CAS  PubMed  Google Scholar 

  17. Aicher A, Zeiher AM, Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension. 2005;45:321–5.

    Article  CAS  PubMed  Google Scholar 

  18. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723–9.

    CAS  PubMed  Google Scholar 

  19. Barnett D, Janossy G, Lubenko A, Matutes E, Newland A, Reilly JT. Guideline for the flow cytometric enumeration of CD34+ haematopoietic stem cells. Clin Lab Haematol. 1999;21:301–8.

    Article  CAS  PubMed  Google Scholar 

  20. Loebinger MR, Janes SM. Stem cells for lung disease. Chest. 2007;132:279–85.

    Article  PubMed  Google Scholar 

  21. Krause DS. Bone marrow-derived lung epithelial cells. Proc Am Thorac Soc. 2008;5:699–702.

    Article  PubMed  Google Scholar 

  22. Rafat N, Hanusch C, Brinkkoetter PT, Schulte J, Brade J, Zijlstra JG, et al. Increased circulating endothelial progenitor cells in septic patients: correlation with survival. Crit Care Med. 2007;35:1677–84.

    Article  PubMed  Google Scholar 

  23. Borghesi A, Massa M, Campanelli R, Bollani L, Tzialla C, Figar TA, et al. Circulating endothelial progenitor cells in preterm infants with bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2009;180:540–6.

    Article  PubMed  Google Scholar 

  24. Baker CD, Ryan SL, Ingram DA, Seedorf GJ, Abman SH, Balasubramaniam V. Endothelial colony-forming cells from preterm infants are increased and more susceptible to hyperoxia. Am J Respir Crit Care Med. 2009;180:454–61.

    Article  PubMed  Google Scholar 

  25. Abe S, Boyer C, Liu X, Wen FQ, Kobayashi T, Fang Q, et al. Cells derived from the circulation contribute to the repair of lung injury. Am J Respir Crit Care Med. 2004;170:1158–63.

    Article  PubMed  Google Scholar 

  26. Kähler CM, Wechselberger J, Hilbe W, Gschwendtner A, Colleselli D, Niederegger H, et al. Peripheral infusion of rat bone marrow derived endothelial progenitor cells leads to homing in acute lung injury. Respir Res. 2007;8:50.

    Article  PubMed  Google Scholar 

  27. Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol. 2002;30:973–81.

    Article  CAS  PubMed  Google Scholar 

  28. Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med. 1997;185:111–20.

    Article  CAS  PubMed  Google Scholar 

  29. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation. 2004;110:3300–5.

    Article  PubMed  Google Scholar 

  30. De Falco E, Porcelli D, Torella AR, Straino S, Iachininoto MG, Orlandi A, et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood. 2004;104:3472–82.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Mrs. Qian Zhang and Ying Wang for the flow cytometry analysis, and assistance by staff from the Department of Neonatology is highly appreciated. This study was supported by the National Natural Science Foundation (No. 30600687) of China.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Liling Qian.

Additional information

Responsible Editor: A. Bauhofer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Qi, Y., Qian, L., Sun, B. et al. Circulating CD34+ cells are elevated in neonates with respiratory distress syndrome. Inflamm. Res. 59, 889–895 (2010). https://doi.org/10.1007/s00011-010-0201-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00011-010-0201-9

Keywords

Navigation